As Robert F. Kennedy Jr. signals a fat-friendlier approach to dietary guidelines, a new review offers fodder for opposing ...

In a memo obtained by STAT, the NIH gives specific steps on how grant reviewers can check for alignment with administration ...

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

The Medicare prescription drug plan market appears to be under a lot of stress. And taxpayers are forking over record amounts ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

After years of counseling families through loss, I am still moved by their strength. I carry with me Eleanor’s prayer, ...

Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...